Download PDF
Thromb Haemost 1979; 41(03): 583-589
DOI: 10.1055/s-0038-1646811
Original Articles
Schattauer GmbH Stuttgart

Measurement of the Heparin Neutralizing Capacity of Protamine

David T Graham
The National Biological Standards Laboratory, Department of Health, Canberra, A.C.T., Australia
,
Alan R Pomeroy
The National Biological Standards Laboratory, Department of Health, Canberra, A.C.T., Australia
,
David B Smythe
The National Biological Standards Laboratory, Department of Health, Canberra, A.C.T., Australia
› Author Affiliations
Further Information

Publication History

Received 21 April 1978

Accepted 08 June 1978

Publication Date:
09 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Several methods of estimating the heparin neutralizing capacity of protamine were investigated for their reliability and practicability. The results from two chemical methods were compared with those from two in vitro biological assays, one of which was the method of the British Pharmacopoeia (1973). An in vivo method using mice was used to assess the accuracy of the in vitro test methods. Three standard heparin preparations were tested against the W.H.O. 1st International Reference Preparation for Protamine. Two of the heparin preparations were of mucosal origin, one of which was the 3rd International Standard, and the third heparin preparation was of lung origin (the 2nd International Standard for Heparin).

The mean neutralization values (all methods) of heparin by protamine for a House Reference Preparation and the 3rd and 2nd International Standards for Heparin were 95.8, 109.8 and 89.9 units per mg of Protamine, respectively. All the methods read the House Reference Preparation to have a lower value than the 3rd International Standard, which had a higher value than the 2nd International Standard for Heparin. There was a constant relationship between the results of any one method and those of another. The chemical and in vitro biological methods gave results of comparable precision although the latter required a greater degree of technical skill and time to perform.

 

  • References

  • 1 Bangham DR, Woodward PM. 1970; A collaborative study of heparins from different sources. Bulletin of the World Health Organization 42: 129
    PubMedSearch in Google Scholar
  • 2 British Pharmacopoeia. 1968. Her Majesty’s Stationery Office; London: p 847
  • 3 British Pharmacopoeia. 1973. Her Majesty’s Stationery Office; London: P A 113
  • 4 Copley AL, Whitney DV. 1943; The standardization and assay of heparin by the toluidine blue and azure A reactions. Journal of Laboratory and Clinical Medicine 28: 762
    PubMedSearch in Google Scholar
  • 5 Lowary LR, Smith FA, Coyne E, Dunham NW. 1971; Comparative neutralization of lung- and mucosal-derived heparin by protamine sulfate using in vitro and in vivo methods. Journal of Pharmaceutical Sciences 60: 638
    CrossrefPubMedSearch in Google Scholar
  • 6 Walton PL, Ricketts CR, Bangham DR. 1966; Heterogeneity of heparin. British Journal of Haematology 12: 310
    CrossrefPubMedSearch in Google Scholar
  • 7 Walton PL, Wright BM. 1974; An automatic coagulometer. Journal of Physiology (London) 172 7P
    PubMedSearch in Google Scholar